Yuan Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuan Gao has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Guangming Wang
School of Clinical Medicine, Dali University, Dali, People’s Republic of China
3 shared publications - Huaqiu Chen
Department of Laboratory, Xichang People’s Hospital, Liangshan, Sichuan, China
2 shared publications - Jianjie Cheng
Department of Neurosurgery, the First Affiliated Hospital of Dali University, Dali, Yunnan 671000, China
2 shared publications - Min Wang
School of Clinical Medicine, Dali University, Dali, Yunnan, People’s Republic of China
2 shared publications - Fang Liu
School of Clinical Medicine, Dali University, Dali, Yunnan, People’s Republic of China
1 shared publication Guangyan Wang
Chuxiong Yi Autonomous Prefecture People's Hospital
1 shared publication
Latest Publications
- Open Access
- 5 July 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (27) , e38877
Identification of core genes shared by ischemic stroke and myocardial infarction using an integrated approach
Background: Both ischemic stroke (IS) and myocardial infarction (MI) are caused by vascular occlusion that results in ischemia. While there may be similarities in their mechanisms, the potential relationship between these 2 diseases has not been comprehensively analyzed. Therefore, this study explored the commonalities in the pathogenesis of IS and MI. Methods: Datasets for IS (GSE58294, GSE16561) and MI (GSE60993, GSE61144) were downloaded from the Gene Expression Omnibus database. Transcriptome data from each of the 4 datasets were analyzed using bioinformatics, and the differentially expressed genes (DEGs) shared between IS and MI were identified and subsequently visualized using a Venn diagram. A protein–protein interaction (PPI) network was constructed using the Interacting Gene Retrieval Tool database, and identification of key core genes was performed using CytoHubba. Gene Ontology (GO) term annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of the shared DEGs were conducted using prediction and network analysis methods, and the functions of the hub genes were determined using Metascape. Results: The analysis revealed 116 and 1321 DEGs in the IS and MI datasets, respectively. Of the 75 DEGs shared between IS and MI, 56 were upregulated and 19 were downregulated. Furthermore, 15 core genes – S100a12, Hp, Clec4d, Cd163, Mmp9, Ormdl3, Il2rb, Orm1, Irak3, Tlr5, Lrg1, Clec4e, Clec5a, Mcemp1, and Ly96 – were identified. GO enrichment analysis of the DEGs showed that they were mainly involved in the biological functions of neutrophil degranulation, neutrophil activation during immune response, and cytokine secretion. KEGG analysis showed enrichment in pathways pertaining to Salmonella infection, Legionellosis, and inflammatory bowel disease. Finally, the core gene–transcription factor, gene–microRNA, and small-molecule relationships were predicted. Conclusion: These core genes may provide a novel theoretical basis for the diagnosis and treatment of IS and MI.
- 5 July 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (27) , e38877
Open AccessIdentification of core genes shared by ischemic stroke and myocardial infarction using an integrated approach
Background: Both ischemic stroke (IS) and myocardial infarction (MI) are caused by vascular occlusion that results in ischemia. While there may be similarities in their mechanisms, the potential relationship between these 2 diseases has not been comprehensively analyzed. Therefore, this study explored the commonalities in the pathogenesis of IS and MI. Methods: Datasets for IS (GSE58294, GSE16561) and MI (GSE60993, GSE61144) were downloaded from the Gene Expression Omnibus database. Transcriptome data from each of the 4 datasets were analyzed using bioinformatics, and the differentially expressed genes (DEGs) shared between IS and MI were identified and subsequently visualized using a Venn diagram. A protein–protein interaction (PPI) network was constructed using the Interacting Gene Retrieval Tool database, and identification of key core genes was performed using CytoHubba. Gene Ontology (GO) term annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of the shared DEGs were conducted using prediction and network analysis methods, and the functions of the hub genes were determined using Metascape. Results: The analysis revealed 116 and 1321 DEGs in the IS and MI datasets, respectively. Of the 75 DEGs shared between IS and MI, 56 were upregulated and 19 were downregulated. Furthermore, 15 core genes – S100a12, Hp, Clec4d, Cd163, Mmp9, Ormdl3, Il2rb, Orm1, Irak3, Tlr5, Lrg1, Clec4e, Clec5a, Mcemp1, and Ly96 – were identified. GO enrichment analysis of the DEGs showed that they were mainly involved in the biological functions of neutrophil degranulation, neutrophil activation during immune response, and cytokine secretion. KEGG analysis showed enrichment in pathways pertaining to Salmonella infection, Legionellosis, and inflammatory bowel disease. Finally, the core gene–transcription factor, gene–microRNA, and small-molecule relationships were predicted. Conclusion: These core genes may provide a novel theoretical basis for the diagnosis and treatment of IS and MI.
- Open Access
- 23 February 2024
- Published by Springer Nature in Research Square
Association of coffee and caffeine consumption with risk of ischemic stroke: a Mendelian randomization study
Background Previous research has not elucidated a causal relationship between coffee and caffeine intake and ischemic stroke. Methods Mendelian randomization (MR) studies were used to assess the causal relationship between coffee and caffeine consumption and the risk of ischemic stroke. Genetic statistically significant single nucleotide polymorphisms (SNPs) for coffee and caffeine intake served as instrumental variables (IVs). Ischemic stroke was used as the outcome, and the IVW, MR-Egger, simple mode, weighted mode, and weighted median methods were used for analysis, and the inverse variance weighting (IVW) method was used as the main method for MR analysis. Further sensitivity analysis was performed using MR-Egger and IVW to assess robustness. Results MR analysis results showed that coffee and caffeine intake were not associated with the risk of ischemic stroke. Twenty-three SNPs of coffee and 19 SNPs of caffeine were selected as IVs, and the F values of all SNPs were greater than 10. The study results show that genetic susceptibility to coffee intake is associated with IS (OR = 1.147, 95% CI: 0.704– 1.869, P = 0.583), and caffeine intake is associated with IS (OR = 0.93, 95% CI: 0.846– 1.021, P = 0.126) had no effect. After excluding SNPs with confounding factors, a sensitivity analysis was performed in this study, and the results were consistent. Conclusion The findings suggest there is insufficient evidence to support an association between coffee and caffeine intake and the risk of ischemic stroke. More research is needed to verify this in the future.
- 23 February 2024
- Published by Springer Nature in Research Square
Open AccessAssociation of coffee and caffeine consumption with risk of ischemic stroke: a Mendelian randomization study
Background Previous research has not elucidated a causal relationship between coffee and caffeine intake and ischemic stroke. Methods Mendelian randomization (MR) studies were used to assess the causal relationship between coffee and caffeine consumption and the risk of ischemic stroke. Genetic statistically significant single nucleotide polymorphisms (SNPs) for coffee and caffeine intake served as instrumental variables (IVs). Ischemic stroke was used as the outcome, and the IVW, MR-Egger, simple mode, weighted mode, and weighted median methods were used for analysis, and the inverse variance weighting (IVW) method was used as the main method for MR analysis. Further sensitivity analysis was performed using MR-Egger and IVW to assess robustness. Results MR analysis results showed that coffee and caffeine intake were not associated with the risk of ischemic stroke. Twenty-three SNPs of coffee and 19 SNPs of caffeine were selected as IVs, and the F values of all SNPs were greater than 10. The study results show that genetic susceptibility to coffee intake is associated with IS (OR = 1.147, 95% CI: 0.704– 1.869, P = 0.583), and caffeine intake is associated with IS (OR = 0.93, 95% CI: 0.846– 1.021, P = 0.126) had no effect. After excluding SNPs with confounding factors, a sensitivity analysis was performed in this study, and the results were consistent. Conclusion The findings suggest there is insufficient evidence to support an association between coffee and caffeine intake and the risk of ischemic stroke. More research is needed to verify this in the future.
- Open Access
- 17 November 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (46) , e35919
Bioinformatics strategies to identify differences in molecular biomarkers for ischemic stroke and myocardial infarction
Ischemic strokes (ISs) are commonly treated by intravenous thrombolysis using a recombinant tissue plasminogen activator; however, successful treatment can only occur within 3 hours after the stroke. Therefore, it is crucial to determine the causes and underlying molecular mechanisms, identify molecular biomarkers for early diagnosis, and develop precise preventive treatments for strokes. We aimed to clarify the differences in gene expression, molecular mechanisms, and drug prediction approaches between IS and myocardial infarction (MI) using comprehensive bioinformatics analysis. The pathogenesis of these diseases was explored to provide directions for future clinical research. The IS (GSE58294 and GSE16561) and MI (GSE60993 and GSE141512) datasets were downloaded from the Gene Expression Omnibus database. IS and MI transcriptome data were analyzed using bioinformatics methods, and the differentially expressed genes (DEGs) were screened. A protein–protein interaction network was constructed using the STRING database and visualized using Cytoscape, and the candidate genes with high confidence scores were identified using Degree, MCC, EPC, and DMNC in the cytoHubba plug-in. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of the DEGs were performed using the database annotation, visualization, and integrated discovery database. Network Analyst 3.0 was used to construct transcription factor (TF) – gene and microRNA (miRNA) – gene regulatory networks of the identified candidate genes. The DrugBank 5.0 database was used to identify gene–drug interactions. After bioinformatics analysis of IS and MI microarray data, 115 and 44 DEGS were obtained in IS and MI, respectively. Moreover, 8 hub genes, 2 miRNAs, and 3 TFs for IS and 8 hub genes, 13 miRNAs, and 2 TFs for MI were screened. The molecular pathology between IS and MI presented differences in terms of GO and KEGG enrichment pathways, TFs, miRNAs, and drugs. These findings provide possible directions for the diagnosis of IS and MI in the future.
- 17 November 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (46) , e35919
Open AccessBioinformatics strategies to identify differences in molecular biomarkers for ischemic stroke and myocardial infarction
Ischemic strokes (ISs) are commonly treated by intravenous thrombolysis using a recombinant tissue plasminogen activator; however, successful treatment can only occur within 3 hours after the stroke. Therefore, it is crucial to determine the causes and underlying molecular mechanisms, identify molecular biomarkers for early diagnosis, and develop precise preventive treatments for strokes. We aimed to clarify the differences in gene expression, molecular mechanisms, and drug prediction approaches between IS and myocardial infarction (MI) using comprehensive bioinformatics analysis. The pathogenesis of these diseases was explored to provide directions for future clinical research. The IS (GSE58294 and GSE16561) and MI (GSE60993 and GSE141512) datasets were downloaded from the Gene Expression Omnibus database. IS and MI transcriptome data were analyzed using bioinformatics methods, and the differentially expressed genes (DEGs) were screened. A protein–protein interaction network was constructed using the STRING database and visualized using Cytoscape, and the candidate genes with high confidence scores were identified using Degree, MCC, EPC, and DMNC in the cytoHubba plug-in. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of the DEGs were performed using the database annotation, visualization, and integrated discovery database. Network Analyst 3.0 was used to construct transcription factor (TF) – gene and microRNA (miRNA) – gene regulatory networks of the identified candidate genes. The DrugBank 5.0 database was used to identify gene–drug interactions. After bioinformatics analysis of IS and MI microarray data, 115 and 44 DEGS were obtained in IS and MI, respectively. Moreover, 8 hub genes, 2 miRNAs, and 3 TFs for IS and 8 hub genes, 13 miRNAs, and 2 TFs for MI were screened. The molecular pathology between IS and MI presented differences in terms of GO and KEGG enrichment pathways, TFs, miRNAs, and drugs. These findings provide possible directions for the diagnosis of IS and MI in the future.